Cocrystal Pharma, Inc. Announces License Agreement with Kansas State University Research Foundation for Norovirus and Coronavirus Antiviral Compounds

Stock Information for Cocrystal Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.